r | p | n | Mean | Median | Minimum | Maximum | |
---|---|---|---|---|---|---|---|
Δ EQ-5D-3L | − 0.50 | < 0.001 | 51 | 0.18* | 0.12 | − 0.36 | 91.2 |
Δ EQ VAS | − 0.57 | < 0.001 | 50 | 10.5 | 10.0 | − 40.0 | 90.0 |
Δ VascuQoL | − 0.72 | < 0.001 | 52 | 1.1 | 1.0 | − 1.2 | 4.5 |
Δ Stage of PAD | 0.46 | < 0.001 | 46 | 1.0* | 1.0 | − 2 | 4 |
Δ Global rating of impairment | 0.64 | < 0.001 | 50 | 1.3* | 1.0 | − 1 | 4 |
Global rating of symptom improvement | − 0.55 | < 0.001 | 51 | 1.7* | 1.0 | 1 | 4 |
Global rating of treatment effectiveness | 0.46 | 0.001 | 51 | 2.8* | 3.0 | 0 | 4 |
Global rating of recommendation of treatment | 0.47 | 0.001 | 51 | 3.2* | 4.0 | 0 | 4 |